Resistin as a Novel Prognostic Biomarker in Patients with Chronic Liver Diseases

Mina Adel Elkomos Mikhael Hanna;

Abstract


Chronic liver diseases (CLD) are the 10th leading cause of death for men and the 12th for women in the United States. In Egypt, it was found that approximately 7% of all Egyptian deaths annually are associated with liver cirrhosis.

Features of wound hea


Other data

Title Resistin as a Novel Prognostic Biomarker in Patients with Chronic Liver Diseases
Other Titles الريزيستين كدلالة كيميائية تنبؤية جديدة فى مرضى الكبد المزمنين
Authors Mina Adel Elkomos Mikhael Hanna
Keywords Resistin as a Novel Prognostic Biomarker in Patients with Chronic Liver Diseases
Issue Date 2009
Description 
Chronic liver diseases (CLD) are the 10th leading cause of death for men and the 12th for women in the United States. In Egypt, it was found that approximately 7% of all Egyptian deaths annually are associated with liver cirrhosis.

Features of wound hea

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.